Abstract
Risk Management Plan Issued for Erythropoietin; U.S.–European Agreement to Reduce Burden of Orphan Drug Documentation; New Product Approvals from FDA; FDA, NIH Form Partnership to Improve Regulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have